Noma and Novonesis partner to scale deliciousness Noma and Novonesis partner to scale deliciousnessNoma, hailed as one of the world’s best restaurants, is joining forces with Novonesis, the global leader in biosolutions, to take deliciousness to the next level. Together, they’re fusing culinary craft with biology to create flavors and products that are healthier, tastier, and better for the planet. COPENHAGEN, 23 October 2025: Innovation pushes boundaries and, at times, returns to the beginning. For thousands of years, we have used biology to craft our rich tapestry of food and beverage tr...
Share buy-back program COMPANY ANNOUNCEMENT NO 52/2025 - October 20, 2025 On August 26, 2025, Royal Unibrew initiated a share buy-back program, cf. company announcement no. 44/2025. The program is carried out under Art. 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of April 16, 2014, on market abuse, as amended (the Market Abuse Regulation - MAR) and the Commission Delegated Regulation (EU) No 2016/1052 of March 8, 2016. The share buy-back program is expected to be realized in the period from August 27, 2025, to December 19, 2025. The total transaction va...
We initiate coverage on Carlsberg with an Outperform recommendation and a DKK 985 TP, valuing the brewer at 12-month EV/EBITDA of 10.7x, EV/EBIT of 14.7x, and P/E of 15.8x. All three European listed brewers in our coverage universe have an attractive valuation. However, we prefer Carlsberg because of its geographical exposure – with a focus on less volatile Europe and Asia – and because of its 30% soft drink exposure, which we conclude is synergistic to beer, adds to growth, and is less debated ...
Share buy-back program COMPANY ANNOUNCEMENT NO 51/2025 - October 13, 2025 On August 26, 2025, Royal Unibrew initiated a share buy-back program, cf. company announcement no. 44/2025. The program is carried out under Art. 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of April 16, 2014, on market abuse, as amended (the Market Abuse Regulation - MAR) and the Commission Delegated Regulation (EU) No 2016/1052 of March 8, 2016. The share buy-back program is expected to be realized in the period from August 27, 2025, to December 19, 2025. The total transaction va...
Share buy-back program COMPANY ANNOUNCEMENT NO 50/2025 - October 6, 2025 On August 26, 2025, Royal Unibrew initiated a share buy-back program, cf. company announcement no. 44/2025. The program is carried out under Art. 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of April 16, 2014, on market abuse, as amended (the Market Abuse Regulation - MAR) and the Commission Delegated Regulation (EU) No 2016/1052 of March 8, 2016. The share buy-back program is expected to be realized in the period from August 27, 2025, to December 19, 2025. The total transaction val...
Novonesis Hosts National Flagship Manufacturing Day Event at North America Headquarters Franklinton, NC, Oct. 06, 2025 (GLOBE NEWSWIRE) -- , a global leader in biosolutions, welcomed hundreds of local students, educators, and community leaders to its facilities in Salem, Virginia; West Allis and Madison, Wisconsin; and its North American headquarters in Franklinton, North Carolina, for the national flagship (MFG Day), a grassroots movement of the (MI). The MI is the workforce development and education affiliate of (NAM). The MI’s mission is to build and strengthen the manufacturing workfo...
Share buy-back program COMPANY ANNOUNCEMENT NO 49/2025 - September 29, 2025 On August 26, 2025, Royal Unibrew initiated a share buy-back program, cf. company announcement no. 44/2025. The program is carried out under Art. 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of April 16, 2014, on market abuse, as amended (the Market Abuse Regulation - MAR) and the Commission Delegated Regulation (EU) No 2016/1052 of March 8, 2016. The share buy-back program is expected to be realized in the period from August 27, 2025, to December 19, 2025. The total transaction ...
Share buy-back program COMPANY ANNOUNCEMENT NO 48/2025 - September 22, 2025 On August 26, 2025, Royal Unibrew initiated a share buy-back program, cf. company announcement no. 44/2025. The program is carried out under Art. 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of April 16, 2014, on market abuse, as amended (the Market Abuse Regulation - MAR) and the Commission Delegated Regulation (EU) No 2016/1052 of March 8, 2016. The share buy-back program is expected to be realized in the period from August 27, 2025, to December 19, 2025. The total transaction ...
Share buy-back program COMPANY ANNOUNCEMENT NO 47/2025 - September 15, 2025 On August 26, 2025, Royal Unibrew initiated a share buy-back program, cf. company announcement no. 44/2025. The program is carried out under Art. 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of April 16, 2014, on market abuse, as amended (the Market Abuse Regulation - MAR) and the Commission Delegated Regulation (EU) No 2016/1052 of March 8, 2016. The share buy-back program is expected to be realized in the period from August 27, 2025, to December 19, 2025. The total transaction ...
Share buy-back program COMPANY ANNOUNCEMENT NO 46/2025 - September 8, 2025 On August 26, 2025, Royal Unibrew initiated a share buy-back program, cf. company announcement no. 44/2025 of August 26, 2025. The program is carried out under Art. 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of April 16, 2014, on market abuse, as amended (the Market Abuse Regulation - MAR) and the Commission Delegated Regulation (EU) No 2016/1052 of March 8, 2016. The share buy-back program is expected to be realized in the period from August 27, 2025, to December 19, 2025. The ...
Novonesis and Novo Nordisk will explore new solutions to improve metabolic health Novonesis and Novo Nordisk join forces in a new research collaboration to explore solutions that seek to preserve and optimize metabolic health and well-being for people. COPENHAGEN, Denmark – September 8, 2025. Novonesis and Novo Nordisk has entered a research partnership to explore the role of the gut microbiome in the maintenance of metabolic health. The gut microbiome is the collection of microorganisms, such as bacteria, fungi, and viruses, that naturally live in the human gut. The science...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.